Patents by Inventor Elizabeth Ann Webb

Elizabeth Ann Webb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polypeptide fragments comprising c terminal portion of helicobacter catalase
    Patent number: 7786260
    Abstract: An isolated polypeptide and immunogenic fragments thereof are described together with their variants and derivatives as novel immunogenic agents for treating or preventing Helicobacter infection in a mammalian host. The polypeptide comprises a C-terminal portion of a Helicobacter catalase, which portion lacks significant amino acid sequence identity with human catalase, wherein the polypeptide is other than full-length Helicobacter catalase.
    Type: Grant
    Filed: October 13, 2000
    Date of Patent: August 31, 2010
    Assignees: CSL Limited, The University of New South Wales
    Inventors: Christopher Vincent Doidge, Elizabeth Ann Webb, Linda Joy Rothel, Phillip Sutton, Stuart Lloyd Hazell
  • Protective helicobacter antigens
    Patent number: 6762295
    Abstract: Protective Helicobacter antigens, especially H. pylori antigens, and the use of these antigens for the treatment of or prevention of, gastroduodenal disease associated with H. pylori infection.
    Type: Grant
    Filed: December 23, 1997
    Date of Patent: July 13, 2004
    Assignees: CSL Limited, The University of New South Wales
    Inventors: Christopher Vincent Doidge, Adrian Lee, Fiona Jane Radcliff, Dianna Margaret Hocking, Elizabeth Ann Webb
  • Papillomavirus polyprotein constructs
    Patent number: 6726912
    Abstract: A papillomavirus polyprotein construct comprises at least two amino acid sequences fused directly or indirectly together, each of the sequences being the sequence of an early ORF protein of papillomavirus or an immunogenic variant or fragment thereof, and at least one of said sequences being other than the E6 or E7 protein sequence or an immunogenic variant or fragment thereof. Nucleic acid molecules encoding the polyprotein construct, prophylactic or therapeutic compositions comprising the polyprotein construct or the nucleic acid molecule, and methods for eliciting an immune response against papillomavirus in a host animal are also provided.
    Type: Grant
    Filed: December 11, 2001
    Date of Patent: April 27, 2004
    Assignees: CSL Limited, University of Queensland of St. Lucia
    Inventors: Elizabeth Ann Webb, Mary Brigid Margetts, John Cooper Cox, Ian Frazer, Nigel Alan John McMillan, Mark Philip Williams, Margaret Bridget Holland Moloney, Stirling John Edwards
  • PROTECTIVE HELICOBACTER ANTIGENS
    Publication number: 20020146423
    Abstract: Protective Helicobacter antigens, especially H. pylori antigens, and the use of these antigens for the treatment of or prevention of, gastroduodenal disease associated with H. pylori infection.
    Type: Application
    Filed: December 23, 1997
    Publication date: October 10, 2002
    Inventors: CHRISTOPHER VINCENT DOIDGE, ADRIAN LEE, FIONA JANE RADCLIFF, DIANNA MARGARET HOCKING, ELIZABETH ANN WEBB
  • Papillomavirus polyprotein constructs
    Patent number: 6365160
    Abstract: Peptides, antibodies and recombinant expression systems or cells that contain and express a DNA insert of HPV encoding a region of a papilloma induced or a papilloma protein, such as E6 or E7, are produced. Compositions containing these peptides, antibodies and/or recombinant cells are utilized as immunogenic compositions and in methods for inhibiting and treating HPV infection and tumor initiation and progression. Specific peptides and recombinant cells, such as vaccinia virus and tumor cells, that express epitopic regions of the HPV16 E6 or E7 nucleoprotein are particularly described.
    Type: Grant
    Filed: April 21, 1998
    Date of Patent: April 2, 2002
    Assignees: CSL Limited, The University of Queensland
    Inventors: Elizabeth Ann Webb, Mary Brigid Margetts, John Cooper Cox, Ian Frazer, Nigel Alan John McMillan, Mark Philip Williams, Margaret Bridget Holland Moloney, Stirling John Edwards
  • Variants of human papilloma virus antigens
    Patent number: 6306397
    Abstract: Variants of human papilloma virus (HPV) E6 and E7 proteins able to elicit a humoral and/or cellular immune response against HPV in a host animal but not being cell-transforming in the host animal are disclosed, and are useful in treatment or prevention of diseases or conditions involving HPV.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: October 23, 2001
    Assignees: CSL Limited, The University of Queensland
    Inventors: Stirling John Edwards, John Cooper Cox, Elizabeth Ann Webb, Ian Frazer
  • Method for protein expression
    Patent number: 6303128
    Abstract: A vector system for expressing foreign proteins or polypeptides in bacteria such as E. coli is disclosed. The vector system is especially useful in obtaining expression of non-transforming variants of human papilloma virus antigens.
    Type: Grant
    Filed: July 23, 1999
    Date of Patent: October 16, 2001
    Assignee: CSL Limited
    Inventors: Elizabeth Ann Webb, Stirling John Edwards
  • Variants of human papillomavirus antigens
    Patent number: 6004557
    Abstract: Variants of human papilloma virus (HPV) E6 and E7 able to elicit a humoral or cellular immune response against HPV in a host animal but not being cell-transforming in the host animal are disclosed, and are useful in treatment or prevention of diseases or conditions involving HPV.
    Type: Grant
    Filed: September 22, 1997
    Date of Patent: December 21, 1999
    Assignees: CSL Limited, The University of Queensland
    Inventors: Stirling John Edwards, John Cooper Cox, Elizabeth Ann Webb, Ian Frazer